Penetrance of familial hypertrophic cardiomyopathy

被引:0
|
作者
Charron, P
Carrier, L
Dubourg, O
Tesson, F
Desnos, M
Richard, P
Bonne, G
Guicheney, P
Hainque, B
Bouhour, JB
Mallet, A
Feingold, J
Schwartz, K
Komajda, M
机构
[1] HOP LA PITIE SALPETRIERE,SERV CARDIOL,F-75651 PARIS 13,FRANCE
[2] HOP LA PITIE SALPETRIERE,INSERM U153,F-75651 PARIS 13,FRANCE
[3] HOP LA PITIE SALPETRIERE,SERV BIOCHIM,F-75651 PARIS 13,FRANCE
[4] HOP AMBROISE PARE,SERV CARDIOL,BOULOGNE,FRANCE
[5] HOP BOUCICAULT,SERV CARDIOL,PARIS,FRANCE
[6] HOP LAENNEC,SERV CARDIOL,NANTES,FRANCE
[7] INSERM U436,PARIS,FRANCE
[8] INSERM U155,UNITE RECH EPIDEMIOL GENET,PARIS,FRANCE
来源
GENETIC COUNSELING | 1997年 / 8卷 / 02期
关键词
hypertrophic cardiomyopathy; penetrance; genetic counseling; linkage analysis;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant cardiac disease for which the penetrance remains a much-debated issue. Since the recent identification of the genes involved in the disease, the penetrance of FHC has not been reassessed in a large genotyped population. The aim of our study was therefore to evaluate it, according to age and sex, in ten families with previously identified mutations. Among 178 individuals we studied, 90 were genetically affected (9 different mutations in 3 genes). We found that penetrance, assessed by classical echocardiographic and electrocardiographic criteria, was (1) incomplete: 69%; (2) age-related: 55% between 10 and 29 years old, 75% between 30 and 49 y. and 95% over 50 y.; (3) greater in males than in females: 77% vs 58%, age-adjusted odds ratio: 3.98, CI 95%: 1.34 to 11.48; (4) similar for the genes analyzed. The consequences of these results for genetic counseling and linkage analyses are discussed.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [41] Age-related penetrance in genetic carriers of hypertrophic cardiomyopathy
    Perez, I.
    Romero-Puche, A.
    Sabater-Molina, M.
    Garcia-Molina, E.
    Gomez-Milanes, I.
    Lopez-Cuenca, D.
    Ruiz-Espejo, F.
    Gimeno, J. R., Jr.
    Valdes M, M.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 877 - 877
  • [42] Molecular basis for penetrance in two families with familial hypertrophic cardiomyopathy (FHC) due to MYBPC3 mutations.
    Yu, B
    French, JA
    Carrier, L
    Jeremy, RW
    McTaggart, DR
    Nicholson, MR
    Hambly, B
    Semsarian, C
    Richmond, DR
    Schwartz, K
    Trent, RJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A352 - A352
  • [43] SIGNIFICANCE OF HLA ANALYSIS AND PENETRANCE OF ASH IN FAMILIAL CARDIOMYOPATHY WITH COEXISTING HYPERTROPHIC AND DILATED-LIKE TYPES IN 2 FAMILIES
    KISHIMOTO, C
    TOMIOKA, N
    KAWAI, C
    TAMAKI, S
    KADOTA, K
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1985, 49 (11): : 1213 - 1213
  • [44] Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury
    Marian, AJ
    Roberts, R
    [J]. ANNALS OF MEDICINE, 1998, 30 : 24 - 32
  • [45] FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (HCM) SIMILAR TO DILATED CARDIOMYOPATHY (DCM)
    TAKEZAWA, H
    ISAKA, N
    MORITA, N
    KODERA, T
    NAKANO, T
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1984, 48 (09): : 1054 - 1054
  • [46] AMP kinase mutations in hypertrophic cardiomyopathy: Prevalence, penetrance, and clinical characterisation
    Ward, D
    Shah, JS
    Tome, M
    Murphy, RT
    Elliott, PM
    McKenna, WJ
    [J]. HEART, 2004, 90 : A45 - A45
  • [47] Genetics of AMP kinase in hypertrophic cardiomyopathy: prevalance, penetrance and disease expression
    Murphy, RT
    Mogensen, J
    Bahl, A
    Kubo, T
    O'Donoghue, A
    McGarry, K
    McKenna, WJ
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 589 - 589
  • [48] Familial hypertrophic cardiomyopathy:a report of 11 cases
    吕学苏
    吕玉芝
    于文奎
    田智华
    李建华
    房秀之
    [J]. 中华医学杂志(英文版), 1998, (01) : 94 - 95
  • [49] ASSESSMENT OF THE MOLECULAR DEFECT IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    STRACESKI, AJ
    GEISTERFERLOWRANCE, A
    LOVE, T
    WATKINS, H
    SEIDMAN, CE
    SEIDMAN, JG
    LEINWAND, LA
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 203 - 203
  • [50] A transgenic mouse model of familial hypertrophic cardiomyopathy
    Ohta, M
    Takaoka, Y
    Suzuki, M
    Takahashi, F
    Minakami, R
    Sasaguri, T
    Ohtsuki, I
    Yamamura, K
    Morimoto, S
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 63P - 63P